GABY Inc. Congratulates Board Member Javier Estades on Being Named Chairman of the Cigar Association of America

Estades' expertise in the world of retail and premium consumer packaged goods make him a well-suited leader of the CCA, and an asset to GABY's Board of Directors, shareholders and stakeholders

GABY Inc. ("GABY" or the "Company") (CSE:GABY) (OTCQB:GABLF), a California consolidator of cannabis dispensaries and the parent company of San Diego's Mankind Dispensary ("Mankind"), is proud to congratulate Board Member Javier Estades on his recent appointment as Chairman of the Cigar Association of America.

Mr. Estades, in addition to his board appointment with GABY, serves as President and Chief Executive Officer of cigar giant Tabacalera USA Inc., whose portfolio includes highly respected brands such as Montecristo, Romeo y Julieta, H. Upmann, Casa de Garcia and others.

"Javier brings a tremendous knowledge of the premium retail and CPG environments to GABY, and we congratulate him on his appointment with the CAA" said GABY Founder and CEO Margot Micallef. "We look forward to benefiting from Javier's expansive expertise as we continue to make steps towards multi-unit retail consolidation."

Founded in 1937, the Cigar Association of America is a national association which represents large swaths of the cigar industry, including importers, distributors, manufacturers, and suppliers.

Mr. Estades thanked GABY for their support, saying "The similarities between the high-end cigar industry and the cannabis industry are many. Success in both the premium cigar world and the cannabis world is founded on providing a high quality customer experience and as such engender substantial brand loyalty. I've greatly enjoyed playing an active role in GABY's success, and see a bright future based on the tremendous brand loyalty enjoyed by their flagship Mankind Dispensary. I look forward to sharing my experience and having an active role in what I believe will be a highly successful California wide retail brand. I would like to thank GABY Inc. and Margot for their warm and public congratulations."

For more on this story go to:

About GABY Inc.

GABY Inc. is a California-focused retail consolidator and the owner of Mankind Dispensary, one of the oldest licensed dispensaries in California. Mankind is a well-known, and highly respected dispensary with deep roots in the California cannabis community operating in San Diego, California. GABY curates and sells a diverse portfolio of products, including its own proprietary brands, Lulu's™ and Kind Republic™ through Mankind, manufactures Kind Republic, and distributes all its proprietary brands through its wholly owned subsidiary, Wild West Industries Inc.. A pioneer in the industry with a strong management team having experience in retail, consolidation, and cannabis, GABY is poised to grow its retail operations both organically and through acquisition.

GABY's shares trade on the Canadian Securities Exchange ("CSE") under the symbol "GABY" and on the OTCQB under the symbol "GABLF". For more information on GABY, visit

Media Contact:

Senior Communications Manager
Charlie Rohlfs
This email address is being protected from spambots. You need JavaScript enabled to view it.


Margot Micallef, Founder & CEO
or Investor Relations at This email address is being protected from spambots. You need JavaScript enabled to view it. or 800-674-2239

Disclaimer and Forward-Looking Information

The CSE does not accept responsibility for the adequacy or accuracy of this release. Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties, certain of which are beyond the control of the Company. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Forward-looking statements include, but are not limited to, the Company's future business strategy, including its plans to expand organically and through future acquisitions and the Company's anticipated benefits from its engagement with Hybrid Financial. Although GABY believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because GABY can give no assurance that they will prove to be correct. By its nature, such forward-looking information is subject to various risks and uncertainties, which could cause the actual results and expectations to differ materially from the anticipated results or expectations expressed. Without limitation, these risks and uncertainties include: the severity of the COVID-19 pandemic; risks associated with the cannabis industry in general; failure to benefit from partnerships or successfully integrate acquisitions; actions and initiatives of federal, state and provincial governments and changes to government policies and the execution and impact of these actions, initiatives and policies; the size of the medical-use and adult-use cannabis market; competition from other industry participants; adverse U.S., Canadian and global economic conditions; failure to comply with certain regulations; and departure of key management personnel or inability to attract and retain talent. GABY undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Each of Mankind and Wild West Industries, are subsidiaries of GABY and hold a cannabis license in the State of California. Readers are cautioned that unlike in Canada which has Federal 032320-F legislation uniformly governing the cultivation, distribution, sale and possession of medical cannabis under the Cannabis Act (Federal), in the United States ("U.S."), cannabis is largely regulated at the State level. Cannabis is legal in the State of California; however, cannabis remains illegal under U.S. federal laws. Notwithstanding the permissive regulatory environment of cannabis at the State level, cannabis continues to be categorized as a controlled substance under the Controlled Substances Act in the U.S. and as such, cannabis-related practices or activities, including without limitation, the manufacture, importation, possession, use or distribution of cannabis are illegal under U.S. federal law. To the knowledge of the Company, the businesses operated by each of GABY's subsidiaries are conducted in a manner consistent with the State law of California, as applicable, and are in compliance with regulatory and licensing requirements applicable in the State of California, respectively. However, readers should be aware that strict compliance with State laws with respect to cannabis will neither absolve GABY, or its subsidiary of liability under U.S. federal law, nor will it provide a defense to any federal proceeding in the U.S. which could be brought against any of GABY, or its subsidiary. Any such proceedings brought against GABY, or its subsidiary may materially adversely affect the Company's operations and financial performance generally in the U.S. market specifically.


Buy $GABLF on TDAmeritrade

Buy $GABLF on ETrade

Buy $GABLF on Interactive Brokers


Last Trade: US$0.035
Daily Change: 0.0014 4.23
Daily Volume: 10,500
Market Cap: US$10.970M
GABY Inc. Leadership Team Steers San Diego's Mankind Dispensary Towards Major Operation, Cultural, and Community Impact Improvements
Gaby Inc Announces Engagement with Veteran Firm Hybrid Financial Ltd., to Help Get the GABY Story Out to New Investors and Interested Parties
GABY Owned Mankind Dispensary Joins Inc. Magazine’s 2021 List of America’s Top 5,000 Growing Companies
GABY Inc. Reports Q2 2021 Record Revenue of $11.3MM and a Gross Profit Margin of 35%
GABY Signs 20-Year Veteran Executive Marshall Minor as Chief Financial Officer and Continues to Consolidate its Asset Base and Realize Synergies within its California Operations
GABY Inc. Further Strengthens its Board of Directors with the Appointment of Loreto Grimaldi
GABY Owned, Mankind Dispensary Announces State-Wide Launch of New Lifestyle Cannabis Brand, Kind Republic(TM)
Gaby Inc. Reports Q1 2021 Revenue of $3.4MM and Record First Quarter 2021 Pro Forma Revenue of $12.3MM
GABY INC. Announces It Will File Its 2020 Annual Financial Statements and Related Management's Discussion and Analysis on May 7th, 2021
GABY Inc. Closes Merger with Mankind Dispensary and Resumes Trading
Gaby Inc. Announces Execution Of Definitive Agreement In Respect Of Its Merger With Mankind Dispensary
GABY Inc. Announces Closing of Financing as It Marches Toward Completing Its Acquisition of Mankind Dispensary